Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid (Q36179737)

12 August 2017

Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid (English)

1 reference

12 August 2017

Zurenko GE

1

1 reference

12 August 2017

Ford CW

2

1 reference

12 August 2017

Hutchinson DK

3

1 reference

12 August 2017

Brickner SJ

4

1 reference

12 August 2017

Barbachyn MR

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

2

1 reference

12 August 2017

151-158

1 reference

Inactivation of antibiotics and the dissemination of resistance genes

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

Prevention of drug access to bacterial targets: permeability barriers and active efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

Resistance to antibiotics mediated by target alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.2.151

21 January 2018

Identifiers

DOI

10.1517/13543784.6.2.151

1 reference

12 August 2017

1 reference